- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of this study is to evaluate the urodynamic variables of male subjects with LUTS and BOO treated with the co-administration of 6 mg solifenacin succinate and TOCAS, and 9 mg solifenacin succinate and tamsulosin OCAS versus placebo.
Inclusion criteria
- Storage and Voiding Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)